Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142804 |
| CAS No | NA |
| Mol.F. | C17H16Cl2N2O4 |
| Mol.Wt. | 383.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142805 |
| CAS No | NA |
| Mol.F. | C18H18N2O2 |
| Mol.Wt. | 294.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142806 |
| CAS No | NA |
| Mol.F. | C18H18N2O2 |
| Mol.Wt. | 294.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142807 |
| CAS No | NA |
| Mol.F. | C18H20N2O3 |
| Mol.Wt. | 312.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142808 |
| CAS No | NA |
| Mol.F. | C18H18N2O2 |
| Mol.Wt. | 294.35 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142809 |
| CAS No | NA |
| Mol.F. | C9H12N2O2 |
| Mol.Wt. | 180.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142810 |
| CAS No | NA |
| Mol.F. | C15H20N2O3 |
| Mol.Wt. | 276.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142811 |
| CAS No | NA |
| Mol.F. | C15H20N2O2 |
| Mol.Wt. | 260.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142812 |
| CAS No | NA |
| Mol.F. | C15H22N2O2 |
| Mol.Wt. | 262.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142813 |
| CAS No | NA |
| Mol.F. | C15H10ClN3O2 |
| Mol.Wt. | 299.71 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142814 |
| CAS No | NA |
| Mol.F. | C16H12ClN3O2 |
| Mol.Wt. | 313.74 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142815 |
| CAS No | NA |
| Mol.F. | C25H22ClN3O3 |
| Mol.Wt. | 447.92 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142816 |
| CAS No | NA |
| Mol.F. | C14H12ClN3O |
| Mol.Wt. | 273.72 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142817 |
| CAS No | NA |
| Mol.F. | C10H12N2O3S2 |
| Mol.Wt. | 272.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142818 |
| CAS No | NA |
| Mol.F. | C10H15N3O5S3 |
| Mol.Wt. | 353.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142819 |
| CAS No | NA |
| Mol.F. | C10H13N3O6S3 |
| Mol.Wt. | 367.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |